Understanding Endoscopy in the Realm of GI Cancers: Efforts to Advance the Field
March 31st 2023In this sixth episode of OncChats: Understanding Endoscopy in the Realm of GI Cancers, Madappa Kundranda, MD, PhD, and Toufic A. Kachaamy, MD, share efforts to increase awareness around endoscopy in gastrointestinal cancer.
Understanding Endoscopy in the Realm of GI Cancers: Endoscopic Oncology and Existing Barriers
March 29th 2023In this fifth episode of OncChats: Understanding Endoscopy in the Realm of GI Cancers, Madappa Kundranda, MD, PhD, and Toufic A. Kachaamy, MD, review the potential role for endoscopic ablation in gastrointestinal cancer.
Understanding Endoscopy in the Realm of GI Cancers: Endoscopic Cancer Resection
March 24th 2023In this fourth episode of OncChats: Understanding Endoscopy in the Realm of GI Cancers, Madappa Kundranda, MD, PhD, and Toufic A. Kachaamy, MD, provide insight on the use of endoscopic submucosal resection and endoscopic evaluation for tumor response as it pertains to organ preservation in gastrointestinal cancer.
Understanding Endoscopy in the Realm of GI Cancers: Examining the Role of Endoscopy
March 22nd 2023In this third episode of OncChats: Understanding Endoscopy in the Realm of GI Cancers, Madappa Kundranda, MD, PhD, and Toufic A. Kachaamy, MD, highlight the advantages and scope of endoscopic procedures in gastrointestinal cancer.
Understanding Endoscopy in the Realm of GI Cancers: Interventional Oncology
March 17th 2023In this second episode of OncChats: Understanding Endoscopy in the Realm of GI Cancers, Madappa Kundranda, MD, PhD, and Toufic A. Kachaamy, MD, explain the evolution of minimally invasive surgery and the emergence of interventional radiology in gastrointestinal cancer.
Understanding Endoscopy in the Realm of GI Cancers: Multidisciplinary Care
March 15th 2023In this first episode of OncChats: Understanding Endoscopy in the Realm of GI Cancers, Madappa Kundranda, MD, PhD, and Toufic A. Kachaamy, MD, discuss the importance of endoscopic oncology as it relates to rising cancer incidence and multidisciplinary care in gastrointestinal cancer.
Dr. Dorff on the Continued Investigation of Upfront Chemotherapy in mHSPC
March 10th 2023Tanya Dorff, MD, discusses key data supporting the use of intensified triplet regimens in metastatic hormone-sensitive prostate cancer, and remaining questions regarding the role of chemotherapy agents in these combinations.
Barriers to Confirmatory Trial Enrollment Present Unique Hurdles for Accelerated Approvals
February 8th 2023Despite the favorable comments and interest in clinical trials, the objective fact is that a distressingly low percentage of patients with cancer, in the range of 2% to 4%, are enrolled in clinical investigative efforts.